![[Pack of 2] Multi Collagen Supplements for Women - 10,000mg Type I, II, III, V & X Hydrolysed Marine Collagen Powder, Bovine Collagen, Egg & Cartilage Collagen Peptides for Skin, Hair, Nails & Joints](https://m.media-amazon.com/images/I/61yBhnLdFNL._AC_SY145_.jpg)
这个市场不值得进入:新品成功率是0%,而且新品牌里没有任何真正可复制的盈利样本,已经进入明显的价格战/过度拥挤状态。 从数据看,新增品牌只有13个,虽然还没到30个以上的超饱和警戒线,但近20个新发布产品全部不盈利,70%的已知利润率产品低于10%,说明不是“做得更好”就能赢,而是被低价和投放成本压死。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
这个市场不值得进入:利润率低、价格战明显,而且新品牌几乎全军覆没。 以用户50万CNY预算来看,表面上能开局,但只够覆盖前期少量备货/物流/投放,连长期品牌投入、研发和认证都不算进去,实际抗风险能力不够。
Alternative solutions may pose a risk to your investment in certain markets.
结论很明确:这个市场不值得进入,已经是高强度价格战市场。 近20个新品里没有一个盈利,市场新品成功率是0%,而多数新品利润率落在10%以下,说明不是靠“做得更好”就能赢,而是被低价和投放成本压到几乎没有空间。
结论很直接:这个市场不值得进入,且已经明显偏向价格战/过度拥挤。 现有数据里,已知利润率的产品中有70%落在10%以下,连新品里也有45%低于10%,而0%的新品达到盈利门槛;这意味着无论大品牌还是小商家,都很难靠正常打法拿到稳定利润。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B08P26Q7Y5 | The Intelligent Health | 2020-11-23 | Yes | £15.97 | 2000pcs | £31940.0 | 11.25% | £3593.25 |
![]() | B084YY2KXB | Revive Naturals | 2018-10-21 | Yes | £14.78 | 2000pcs | £29560.0 | 10.44% | £3086.07 |
![]() | B0CVQBFBG9 | Feel Complete | 2024-02-12 | Yes | £14.99 | 700pcs | £10493.0 | 10.5% | £1101.77 |
![]() | B0CCZLNV35 | ONYX INGREDIENTS 101 | 2023-06-08 | Yes | £19.99 | 50pcs | £999.5 | 13.75% | £137.44 |
![]() | B0BDSC2XTX | Protein Rebel | 2022-09-20 | Yes | £14.99 | 50pcs | £749.5 | 10.32% | £77.35 |
New products with negative profitability ranked by lowest profit value. Only includes newly released products classified as non-profitable.
![]() | B0G3X7Q1G7 | Yin & Yang Superfoods | 2025-11-25 | No | £15.66 | 50pcs | £783.0 | 4.85% | £37.98 |
![]() | B0G3XGVNQQ | REFINED NUTRITION | 2025-12-08 | No | £16.99 | 30pcs | £509.7 | 8.49% | £43.28 |
![]() | B0G2H3YZ7Q | chenyayun | 2025-11-15 | No | £17.63 | 50pcs | £881.5 | 7.74% | £68.23 |
![]() | B0G4M4NJZK | seelimGoo | 2025-12-01 | No | £16.78 | 100pcs | £1678.0 | 7.05% | £118.3 |
![]() | B0GFX1BMG6 | 4 | 2026-02-27 | No | £17.82 | 200pcs | £3564.0 | 7.73% | £275.5 |
![]() | B0G39SQ2XZ | GMOLARSUSCO | 2025-12-29 | No | £17.48 | 200pcs | £3496.0 | 8.93% | £312.2 |
![]() | B0G814P3RT | ZyranovaE | 2025-12-17 | No | £18.13 | 200pcs | £3626.0 | 9.31% | £337.59 |
![]() | B0GQVLWLY1 | Nutravita | 2026-03-02 | No | £9.99 | -pcs | £- | -6.87% | £- |
![]() | B0GL3F4T17 | Vitavea | 2026-02-02 | No | £15.68 | -pcs | £- | 9.02% | £- |
![]() | B0GCTXQ6Z1 | welzo | 2025-12-27 | No | £23.22 | -pcs | £- | 12.22% | £- |
![]() | B0GS6L71SL | TailaiMei | 2026-03-11 | No | £18.99 | -pcs | £- | 5.98% | £- |
![]() | B0GY9QLFMX | Roam & Ritual | 2026-04-23 | No | £9.85 | -pcs | £- | -5.58% | £- |
![]() | B0G266ZR7Q | Amaana Wellness | 2025-11-13 | No | £14.99 | -pcs | £- | 10.31% | £- |
![]() | B0GVFN1DL2 | Protein Rebel | 2026-03-30 | No | £- | -pcs | £- | -% | £- |
![]() | B0GNVN3T4L | Amaana Wellness | 2026-02-17 | No | £- | -pcs | £- | -% | £- |
![]() | B0FKV9SBBY | ONYX INGREDIENTS 101 | 2025-08-01 | No | £- | -pcs | £- | -% | £- |
![]() | B0FX4XZC16 | Warrior | 2025-10-21 | No | £- | -pcs | £- | -% | £- |
![]() | B0FKVN3J1C | ONYX INGREDIENTS 101 | 2025-08-01 | No | £- | -pcs | £- | -% | £- |
![]() | B0G72HZH1N | Yin & Yang Superfoods | 2025-12-15 | No | £- | -pcs | £- | -% | £- |
![]() | B0H2Q8TWFR | welzo | 2026-05-23 | No | £- | -pcs | £- | -% | £- |
这个市场不值得进入:新品成功率为0%,整体盈利率只有8.33%,而新品牌新品盈利率也是0%,说明这是一个高度竞争、接近价格战的市场。 你如果现在进场,不管是大品牌还是小品牌,胜率都很低,尤其是新品牌几乎没有可复制的合法成功样本。
What is the ratio of profitable products
What is the ratio of different brands owning all nonprofitable new products
结论很明确:这个市场不值得进入,已经接近价格战/超饱和区。 近一轮新品几乎全军覆没,新品牌新品盈利率为0%,而最近可见的成功也大多不是“真正的新品牌成功”,而是老品牌或依赖旧链接、强营销才能撑住的案例;对大品牌和小企业都不是好机会。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 6 |
| 2026 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 7 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/11 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 1 |
| 2025/12 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 2 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |